Dhoopan or Fumigation in Itching vulva

A Randomised Controlled Clinical Trial to evaluate efficacy of Yonidhoopan by Bruhatiphal-Haridradway in management of Yonikandu in relation to Vulvovaginitis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020104

Enrollment

Registered

2019-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

Intervention1: Yonidhoopan by Bruhatiphal Haridradway in Management of yonikandu in vulvovaginitis: Trial group include 33 patients for Yonidhoopan by bruhatiphal Haridradway twice a day for 7 days. C

Eligibility

Inclusion criteria

Inclusion criteria: Married woman Age 20 to 40 years Clinical sign symptoms of vulvovaginitis that is itching pain in vulvovaginal region redness scratch marks Microscopically positive specimen for Candida albicans Trichomonas Monoliasis E coli

Exclusion criteria

Exclusion criteria: Pregnant women Immuno compromised patients Suspected cases of carcinoma of cervix endometrial carcinoma Known case of Asthma Tuberculosis positive Senile vaginitis Systemic illness like Diabetes mellitus Severe Anaemia Liver disorder Hypertension

Design outcomes

Primary

Measure	Time frame
To reduce pruritis or itching in vulvovaginal regionTimepoint: 1 month	—

Secondary

Measure	Time frame
Reduction in Bacterial flora of vulvovaginitis that is Candida vaginitis Trichomonas vaginalis Monilial E.coli Bacterial vaginosis To reduce pain redness scratch marksTimepoint: 1 month	—

Countries

India

Contacts

Public ContactANITA

All India Institute of Ayurveda

sujatadkadam@gmail.com9818294577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026